Skip to main content
Veterinary Medicines

Orbenin EDC 600 mg/ 3,6 g intramammális szuszpenzió szarvasmarhák részére

Authorised
  • Cloxacillin

Product identification

Medicine name:
Orbenin EDC 600 mg/ 3,6 g intramammális szuszpenzió szarvasmarhák részére
Active substance:
  • Cloxacillin
Target species:
  • Cattle
Route of administration:
  • Intramammary use

Product details

Active substance and strength:
  • Cloxacillin
    765.40
    milligram(s)
    /
    1.00
    Syringe
Pharmaceutical form:
  • Intramammary solution
Withdrawal period by route of administration:
  • Intramammary use
    • Cattle
      • Meat and offal
        49
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ51CF02
Authorisation status:
  • Valid
Authorised in:
  • Hungary
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Zoetis Hungary Kft.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Haupt Pharma Latina S.r.l.
Responsible authority:
  • Directorate Of Veterinary Medicinal Products
Authorisation number:
This information is not available for this product.
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Hungarian (PDF)
Published on: 14/03/2025

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Hungarian (PDF)
Published on: 14/03/2025

Labelling

This document does not exist in this language (English). You can find it in another language below.
Hungarian (PDF)
Published on: 14/03/2025
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."